Practical Methods for Health Economic Evaluation
Graduate House, University of Melbourne
210 - 234 Leicester Street
A three-day intensive computer based course in methods for health economic evaluation. The course is designed for those engaged in undertaking cost-effectiveness analysis and resource allocation decision-making.
The course involves a series of modules to provide an overview of what is required to conduct a health economic evaluation. Modules cover study design principles, techniques for analysing costs and outcomes and an introduction to decision models. Each module is reinforced by exercises in Excel, TreeAge and STATA. The course will be hands-on and participants will be expected to bring a laptop.
Professor Philip Clarke is the Chair in Health Economics at The University of Melbourne.
Dr Kim Dalziel is a Senior Research Fellow and McKenzie Fellow in the Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne.
Dr Natalie Carvalho is a Research Fellow at the Melbourne School of Population and Global Health.
Professor Andrew Palmer is a Professor of Medical Research and the Head of the Health Economics Research Unit at Menzies, University of Tasmania.
Early bird - up until one month before course commencement:
- University/DHSS Employee/Public Sector $1,850 (GST inclusive)
- Private sector $2,850 (GST inclusive)
Normal rates (non-early bird):
- University/DHSS Employee/Public Sector $2,100 (GST inclusive)
- Private sector $3,100 (GST inclusive)
(Lunch, morning tea and afternoon tea will be provided.)
Extensive course notes will be distributed as well as a copy of the widely used Oxford University Press book Applied Methods of Cost-effectiveness Analysis in Healthcare.
Professor Andrew Palmer, University of Tasmania
Professor Andrew Palmer
University of Tasmania
Prof Andrew Palmer is a New Star Professor of Medical Research and the Head of the Health Economics Research Unit at Menzies, working in the field of health economics since 1994. He is a leader in the subject of health economics in chronic diseases, has conducted research and published extensively in many disease areas including aged care/dementia, diabetes, multiple sclerosis, kidney disease, hypertension, dyslipidaemia, osteoporosis, alcoholism, growth hormone deficiency, rheumatoid arthritis, cardiovascular disease and oncology. As well as being the Associate Editor (Health Economics) of Diabetic Medicine, he is the 201315 International Diabetes Federation (IDF) Chairman of the Task Force on Health Economics, the Cofounder/current Steering Committee member of the Mount Hood Modelling Diabetes Group, a Member of the 201315 Heart Foundation Future Fellows Selection Committee, member of the 201315 National Diabetes Strategy Group reporting to the Federal Minister for Health, Member of the Diabetes Australia Health Economics Expert Reference Group, and was an American Diabetes Association panel member for the development of diabetes health economics modelling guidelines.
Dr Natalie Carvalho
Natalie Carvalho is a Research Fellow at the Melbourne School of Population and Global Health. She holds a joint appointment with the Global Burden of Disease Group and the Centre for Health Policy. Natalie is a recipient of the University of Melbourne McKenzie Postdoctoral Fellowship, which was established to attract outstanding recent doctoral graduates to the University in areas of research priority for the university and its faculties, and in particular to recruit new researchers who have the potential to build and lead crossdisciplinary collaborative research activities inside and across faculties. Her research aims to incorporate equity and budgetary considerations into costeffectiveness analyses of interventions to improve maternal and child health in low and middleincome countries, in particular in relation to childhood vaccines. Natalie's prior research focused primarily on prioritysetting of health interventions in low and middleincome countries using costeffectiveness analysis. She has also worked on developing disability weights for injuries and exploring the use of these weights as the basis for a compensation schedule for personal injuries. Natalie's research interests include health inequalities, maternal and child health, immunizations, and quality of care, with a focus on developing countries and marginalized populations. She has conducted impact evaluations and health economic evaluations to inform allocation of resources in resourcepoor settings. Natalie received her BSc (Chemistry) from McGill University, MPH (Epidemiology) from Boston University, and PhD in Health Policy (Decision Sciences) from Harvard University.
Dr Kim Dalziel, Senior Research Fellow
Dr Kim Dalziel
Senior Research Fellow
University of Melbourne
Kim Dalziel is a Senior Research Fellow and McKenzie Fellow in the Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne. She has considerable expertise in modelling health interventions including for regulatory authorities such as PBAC and MSAC in Australia and for the National Institute of Health and Clinical Excellence (NICE) in the UK. Her work has included economic evaluation of complex interventions in areas such as child protection.
Professor Philip Clarke, Chair in Health Economics
Professor Philip Clarke
Chair in Health Economics
University of Melbourne
Professor Philip Clarke is the Chair in Health Economics at The University of Melbourne. Prof Clarke previously spent six years engaged in health economic research at the University of Oxford. His research in Oxford focused on the economic analysis of the United Kingdom Prospective Diabetes Study (UKPDS) – a landmark trial of policies to improve the management of people with Type 2 diabetes. His health economic research interests include developing methods to value the benefits of improving access to health care, health inequalities and the use of simulation models in health economic evaluation. He has over 80 peered review publications and has recently contributed to books on costeffectiveness analysis and costbenefit analysis published by Oxford University Press.